Human Reproduction, Vol. 18, No. 4, 826-833,
April 2003
© 2003 European Society of Human Reproduction and Embryology
Causes of developmental failure of in-vitro matured rhesus monkey oocytes: impairments in embryonic genome activation
1 Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715 and 2 California National Primate Research Center, Davis, CA, USA
3 To whom correspondence should be addressed at: Wisconsin National Primate Research Center, 1223 Capitol Court, Madison, WI 53715, USA. e-mail: schramm{at}primate.wisc.edu
BACKGROUND: Understanding the causes of developmental failure of in-vitro matured primate oocytes may lead to viable strategies for improving their developmental competence. The aims of this study were to determine whether the timely onset of embryonic genome activation among individual blastomeres of preimplantation macaque embryos is impaired by in-vitro maturation (IVM) of oocytes and whether these impairments are associated with developmental failure during the embryonically controlled period of preimplantation development. METHODS: Genome activation among individual blastomeres was assessed using expression of fibrillarin as a marker of nucleolar transcription. Immature oocytes were obtained from rhesus monkeys following treatment with recombinant human FSH and matured in-vitro in one of two IVM media (CMRLa or CMRLb). In-vivo matured oocytes were obtained from FSH treated monkeys following administration of hCG. Oocytes were fertilized in vitro and either cultured for developmental studies or processed at the 8–12-cell stage for expression of fibrillarin. RESULTS: Developmental competence of embryos derived from in-vitro matured CMRLa oocytes was markedly (P < 0.05) impaired compared with those derived from in-vivo matured or in-vitro matured CMRLb oocytes. Developmental profiles were similar among the groups prior to the 8-cell stage. However, in embryos derived from in-vitro matured CMRLa oocytes, developmental failure increased significantly (P < 0.05) after the time of genome activation compared with those derived from in-vivo matured or in-vitro matured CMRLb oocytes. The mean percentages of non-activated blastomeres per embryo, as well as the proportions of embryos with at least one non-activated blastomere, or with no activated blastomeres, were all significantly (P < 0.05) greater in embryos derived from in-vitro matured CMRLa oocytes than in those derived from in-vivo matured or CMRLb oocytes. CONCLUSIONS: The relatively poor developmental competence of in-vitro matured primate oocytes is likely caused in part by failure in the timely onset of embryonic genome activation resulting from incomplete cytoplasmic maturation.
Key words: fibrillarin/genome activation/in-vitro maturation/macaque/oocyte
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. A. VandeVoort, N. R. Mtango, Y. S. Lee, G. W. Smith, and K. E. Latham Differential Effects of Follistatin on Nonhuman Primate Oocyte Maturation and Pre-Implantation Embryo Development In Vitro Biol Reprod, December 1, 2009; 81(6): 1139 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Nyholt de Prada, Y. S. Lee, K. E. Latham, C. L. Chaffin, and C. A. VandeVoort Role for cumulus cell-produced EGF-like ligands during primate oocyte maturation in vitro Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1049 - E1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Lee, K. E. Latham, and C. A. VandeVoort Effects of in vitro maturation on gene expression in rhesus monkey oocytes Physiol Genomics, October 8, 2008; 35(2): 145 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-m. Shu, H.-t. Zeng, Z. Ren, G.-l. Zhuang, X.-y. Liang, H.-w. Shen, S.-z. Yao, P.-q. Ke, and N.-n. Wang Effects of cilostamide and forskolin on the meiotic resumption and embryonic development of immature human oocytes Hum. Reprod., March 1, 2008; 23(3): 504 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Delimitreva, R. Zhivkova, E. Isachenko, N. Umland, and P.L. Nayudu Meiotic abnormalities in in vitro-matured marmoset monkey (Callithrix jacchus) oocytes: development of a non-human primate model to investigate causal factors Hum. Reprod., January 1, 2006; 21(1): 240 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nogueira, R. Ron-El, S. Friedler, M. Schachter, A. Raziel, R. Cortvrindt, and J. Smitz Meiotic Arrest In Vitro by Phosphodiesterase 3-Inhibitor Enhances Maturation Capacity of Human Oocytes and Allows Subsequent Embryonic Development Biol Reprod, January 1, 2006; 74(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zheng, B. Patel, M. McMenamin, E. Moran, A. M. Paprocki, M. Kihara, R. D. Schramm, and K. E. Latham Effects of Follicle Size and Oocyte Maturation Conditions on Maternal Messenger RNA Regulation and Gene Expression in Rhesus Monkey Oocytes and Embryos Biol Reprod, April 1, 2005; 72(4): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Dobson, R. Raja, M. J. Abeyta, T. Taylor, S. Shen, C. Haqq, and R. A. R. Pera The unique transcriptome through day 3 of human preimplantation development Hum. Mol. Genet., July 15, 2004; 13(14): 1461 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zheng, B. Patel, M. McMenamin, S. E. Reddy, A. M. Paprocki, R. D. Schramm, and K. E. Latham The Primate Embryo Gene Expression Resource: A Novel Resource to Facilitate Rapid Analysis of Gene Expression Patterns in Non-Human Primate Oocytes and Preimplantation Stage Embryos Biol Reprod, May 1, 2004; 70(5): 1411 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zheng, W. Si, B. D. Bavister, J. Yang, C. Ding, and W. Ji 17{beta}-Estradiol and progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated prepubertal and adult rhesus monkeys Hum. Reprod., October 1, 2003; 18(10): 2137 - 2144. [Abstract] [Full Text] [PDF]
|
|